WO2001012607B1 - Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers - Google Patents
Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancersInfo
- Publication number
- WO2001012607B1 WO2001012607B1 PCT/FR2000/002310 FR0002310W WO0112607B1 WO 2001012607 B1 WO2001012607 B1 WO 2001012607B1 FR 0002310 W FR0002310 W FR 0002310W WO 0112607 B1 WO0112607 B1 WO 0112607B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- phenyl
- chosen
- alkyl
- methoxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU70122/00A AU7012200A (en) | 1999-08-13 | 2000-08-11 | Pharmaceutical compositions comprising 4-quinolones |
US10/049,512 US6645983B1 (en) | 1999-08-13 | 2000-08-11 | Pharmaceutical compositions comprising 4-quinolones for treating cancers |
IL14810600A IL148106A0 (en) | 1999-08-13 | 2000-08-11 | Pharmaceutical compositions comprising 4-quinolones |
CA002381968A CA2381968A1 (fr) | 1999-08-13 | 2000-08-11 | Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers |
EP00958676A EP1202971A2 (fr) | 1999-08-13 | 2000-08-11 | Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9910492A FR2797444B1 (fr) | 1999-08-13 | 1999-08-13 | Compositions pharmaceutiques comprenant des 4-quinolones |
FR99/10492 | 1999-08-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001012607A2 WO2001012607A2 (fr) | 2001-02-22 |
WO2001012607A3 WO2001012607A3 (fr) | 2001-05-03 |
WO2001012607B1 true WO2001012607B1 (fr) | 2001-11-22 |
Family
ID=9549145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2000/002310 WO2001012607A2 (fr) | 1999-08-13 | 2000-08-11 | Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers |
Country Status (7)
Country | Link |
---|---|
US (1) | US6645983B1 (fr) |
EP (1) | EP1202971A2 (fr) |
AU (1) | AU7012200A (fr) |
CA (1) | CA2381968A1 (fr) |
FR (1) | FR2797444B1 (fr) |
IL (1) | IL148106A0 (fr) |
WO (1) | WO2001012607A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7345018B2 (en) | 2002-04-25 | 2008-03-18 | Reception Aps | Method of treating side effects induced by therapeutic agents |
EA200501518A1 (ru) * | 2003-03-26 | 2006-04-28 | Ресептикон Апс | Применение соединений для профилактики лекарственно-индуцированной клеточной токсичности |
EP2522670A1 (fr) | 2004-04-07 | 2012-11-14 | Takeda Pharmaceutical Company Limited | Antagonistes hétérocycliques des récépteurs du CRF |
TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
KR20110096143A (ko) | 2008-12-05 | 2011-08-29 | 오츠카 세이야쿠 가부시키가이샤 | 퀴놀론 화합물을 포함하는 약제 |
TWI492943B (zh) * | 2008-12-05 | 2015-07-21 | 大塚製藥股份有限公司 | 喹啉酮化合物及藥學組成物(二) |
US8598354B2 (en) * | 2008-12-05 | 2013-12-03 | University Of South Florida | Compounds having antiparasitic or anti-infectious activity |
JP5769504B2 (ja) * | 2010-06-04 | 2015-08-26 | 大塚製薬株式会社 | 医薬 |
CN105017145B (zh) * | 2012-12-12 | 2017-12-05 | 王子厚 | 具有抗肿瘤活性的氯氧喹衍生物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4780793A (en) * | 1992-07-22 | 1994-02-14 | Genelabs Technologies, Inc. | 2-aryl-4-quinolones as antitumor compounds |
US5726184A (en) * | 1995-05-19 | 1998-03-10 | Vertex Pharmaceuticals Incorporated | Tetralin compounds with improved MDR activity |
GB9621757D0 (en) * | 1996-10-18 | 1996-12-11 | Ciba Geigy Ag | Phenyl-substituted bicyclic heterocyclyl derivatives and their use |
-
1999
- 1999-08-13 FR FR9910492A patent/FR2797444B1/fr not_active Expired - Fee Related
-
2000
- 2000-08-11 WO PCT/FR2000/002310 patent/WO2001012607A2/fr not_active Application Discontinuation
- 2000-08-11 IL IL14810600A patent/IL148106A0/xx unknown
- 2000-08-11 CA CA002381968A patent/CA2381968A1/fr not_active Abandoned
- 2000-08-11 US US10/049,512 patent/US6645983B1/en not_active Expired - Fee Related
- 2000-08-11 EP EP00958676A patent/EP1202971A2/fr not_active Withdrawn
- 2000-08-11 AU AU70122/00A patent/AU7012200A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2797444B1 (fr) | 2003-02-07 |
WO2001012607A2 (fr) | 2001-02-22 |
AU7012200A (en) | 2001-03-13 |
WO2001012607A3 (fr) | 2001-05-03 |
CA2381968A1 (fr) | 2001-02-22 |
EP1202971A2 (fr) | 2002-05-08 |
US6645983B1 (en) | 2003-11-11 |
FR2797444A1 (fr) | 2001-02-16 |
IL148106A0 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2325381C2 (ru) | Замещенные гетероциклические производные и их применение | |
KR920701153A (ko) | 옥시인돌 유도체 | |
RU2203894C2 (ru) | Новые производные пиримидина (варианты) | |
TNSN04208A1 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique | |
RU2203274C2 (ru) | Спироциклические ингибиторы металлопротеаз | |
WO2001012607B1 (fr) | Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers | |
KR950704330A (ko) | 면역억제제로서의 라파마이신 카보네이트 에스테르(Rapamycin carbonate esters as immunosuppressant agents) | |
SE8107274L (sv) | 1-sulfo-2-oxazetidinderivat, forfarande for framstellning derav och faramceutisk komposition innehallande desamma | |
RU2007105968A (ru) | Новые пиперидиновые производные для лечения депрессии | |
DE69705480T2 (de) | Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung | |
DE69735442D1 (de) | Antidiabetische mittel | |
RU2005108046A (ru) | 1, 2, 3-триазольные производные, обладающие бактерицидной (например, фунгицидной)активностью | |
ATE343367T1 (de) | Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften und zusammensetzungen damit | |
RU98102128A (ru) | Производные бензо[g]хинолина | |
KR880000390A (ko) | 3-(치환티오)-2-벤조일-시클로헥스-2-에논과 이를 이용한 조성물 및 식물체 억제방법 | |
NO20045327L (no) | Kjemiske forbindelser | |
KR890000477A (ko) | 신규 화합물들 | |
CA2458318A1 (fr) | Analogues de wortmannine et leurs methodes d'utilisation | |
CA2357038A1 (fr) | Compositions medicales contenant des derives de la 1,4-benzothiazepine pour le traitement de la fibrillation auriculaire | |
RU98116122A (ru) | Селективно действующие таксаны, способ их получения и их применение в качестве лекарственных средств | |
DE68909855D1 (de) | 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisochinolin-Derivate, ihre Herstellung und ihre therapeutische Verwendung. | |
KR880000371A (ko) | 치환 3-(치환 옥시)-2-벤조일-시클로헥스-2-에논과 이를 이용한 조성물 및 식물체 억제방법 | |
ES2038166T3 (es) | Procedimiento para preparar un derivado de indenotiazol. | |
HUP9802297A2 (hu) | Fungicid, akaricid és inszekticid hatású haterociklusos trisz-oximino-vegyületek | |
RU2205825C2 (ru) | Производные тиоамидов, способ их получения и фармкомпозиция на их основе |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: B1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
B | Later publication of amended claims | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000958676 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 148106 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2381968 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10049512 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000958676 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000958676 Country of ref document: EP |